PROFESSIONAL AFFILIATIONS


American Society of Addiction Medicine (ASAM): 2005 – Present

Distinguished Fellow (DFASAM)
President: 2017 – Present
President-Elect: 2015 – 2017

Other roles: Director, Chair of Finance Committee, Chair of Legislative Action Committee, Chair of Public Policy Council, Member of Patient Advocacy Task Force, Membership Committee, Chapters Committee, Parity Committees, Pain and Addiction Committee, Pharmacological Issues Workgroup, Utilization Review Accreditation Liaison

Kentucky Society of Addiction Medicine: 2011 – Present
President (2011-2012)
Immediate Past President (2012-2014)

Chair Public Policy Committee (2011-2018)

American Psychiatric Association (APA): 1988 – Present
Distinguished Fellow (DFAPA)

Integration Work Group member (2012-2017)

APA New York State Psychiatric Association Capital District Branch
President-Elect (2012)
Secretary (2011-12)

Executive Committee Liaison for Payment Strategies (2009-2011)

American Medical Association (2014-present)

Kentucky Medical Association (KMA): 2015 – Present

Greater Louisville Medical (GLMS) : 2015 – Present
GLSM Delegate to KMA (2016- present)

KMA Annual Meeting Reference Committee member (2016)

American Association for Physician Leadership

American College of Physician Executives: 2006 – Present
 
International Society of Addiction Medicine: 2011 – Present

TASK FORCES | EXPERT PANELS | WRITING GROUPS


National Rx Drug Abuse Summit: 2012 – Present
Advisory Board Member

Association of Managed Care Pharmacies: 2015 – Present
Member of Addiction Treatment Action Group

The Council of State Governments Justice Center: 2017 – Present
Judges’ and Psychiatrists’ Leadership Initiative, New York, NY
Convening on Behavioral Health Systems of Care and Conditions of Release

National Safety Council: Prescription Drug Overdose Initiative, Arlington, VA: 2016
Prescription Drug Expert Panel

Comptroller General’s Forum: Preventing the use of Illicit Drugs and Abuse of Prescription Drugs: 2016
Participant. Washington, DC

Johns Hopkins Bloomberg School of Public Health: 2015
“The Prescriptions Opioid Epidemic: An Evidence-Based Approach”
Member, Treatment Section Writing Committee

United States Department of Health and Human Services, Rockville, MD: 2014
Substance Abuse and Mental Health Services Administration Buprenorphine Summit
Moderator and participant of work group “Addressing Health Systems and Reimbursement.”

Collaborative Care Research Network, American Academy of Family Practice: 2011 – 2014
Steering Committee Member

New York State Office of Alcohol and Substance Abuse Services Medical Advisory Panel: 2012
Panel Member

Patient Centered Primary Care Collaborative: 2010 – 2012
Behavioral Health Task Force Member

Alliance of Community Health Plan Behavioral Health Medical Directors Network: 2009–2012